Skip to main content
Premium Trial:

Request an Annual Quote

Beckman Coulter s Revenues, Earnings Up in Q4

nNEW YORK, Jan. 30 (GenomeWeb News) - Beckman Coulter reported increased revenues and income today for the fourth quarter of 2003.

 

The company had increased revenues of $638.6 million, up from $595.5 million during the same period last year. Sales in the Biomedical Research sector accounted for $200.4 million of this, compared with $2.1 million the previous year.

 

R&D spending during the quarter grew to $54.9 million, from $45.7 million last year.

 

Net income increased to $70.4 million, or $1.14 per share, from $33.5 million, or $.54 per share, a year ago. Part of this increase is due to a $23 million litigation settlement Beckman received from Flextronics International.

 

As of Dec. 31, 2003, Beckman had cash and cash equivalents of $74.6 million.

The Scan

Two J&J Doses

Johnson & Johnson says two doses of its SARS-CoV-2 vaccine provides increased protection against symptomatic COVID-19, CNN reports.

Pfizer-BioNTech Vaccine Response in Kids

The Pfizer-BioNTech SARS-CoV-2 vaccine in a lower-dose format appears to generate an immune response among children, according to the Washington Post.

Chicken Changes to Prevent Disease

The Guardian writes that researchers are looking at gene editing chickens to help prevent future pandemics.

PNAS Papers on Siberian Dog Ancestry, Insect Reproduction, Hippocampal Neurogenesis

In PNAS this week: ancestry and admixture among Siberian dogs, hormone role in fruit fly reproduction, and more.